Novartis targeting insurers instead of physicians
Pharma Compliance Alert, December 19, 2007
Novartis will start a three-state pilot program in January designed to reorganize its sales force to pay less attention to physicians and more attention to payers, according to an article in the Wall Street Journal.
In some areas, many physicians work for health-maintenance organizations that decide which drugs the physicians are allowed to prescribe based on how well the drugs work and their cost. When the Novartis sales force calls on those organizations, they will try to show Novartis' products are worth their price.
Novartis will begin its program in Minnesota, Oregon, and Washington.
Click here to read more in the Wall Street Journal.
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- HIPAA Q&A: Level of encryption needed for email
- OB services: Coding inside and outside of the package
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- What does case-mix index mean to you?
- ED-to-inpatient transfers are flawed with safety gaps
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Searched
